Recital 20, Directive (EU) 1998/44

In forcesince 6 Jul 1998cited 3×

Whereas, therefore, it should be made clear that an invention based on an element isolated from the human body or otherwise produced by means of a technical process, which is susceptible of industrial application, is not excluded from patentability, even where the structure of that element is identical to that of a natural element, given that the rights conferred by the patent do not extend to the human body and its elements in their natural environment;

  • Judgment of the Court of 9 October 2001. Kingdom of the Netherlands v European Parliament and Council of the European Union.Decision

    Thus, as is stated in the 20th and 21st recitals of the preamble to the Directive, an element of the human body may be part of a product which is patentable but it may not, in its natural environment, be appropriated.

    9 Oct 2001 · 61998CJ0377

  • Judgment of the Court (Grand Chamber) of 18 October 2011. Oliver Brüstle v Greenpeace eV.Decision

    The preamble to the Directive states as follows: ‘… Whereas, in particular in the field of genetic engineering, research and development require a considerable amount of high-risk investment and therefore only adequate legal protection …

    18 Oct 2011 · 62010CJ0034

  • Opinion of Advocate General Cruz Villalón delivered on 17 July 2014. International Stem Cell Corporation v Comptroller General of Patents, DDecision

    Recitals 5, 16, 20, 21, 36 to 39, and 42 of the Directive read as follows: … differences exist in the legal protection of biotechnological inventions offered by the laws and practices of the different Member States; … such differences …

    17 Jul 2014 · 62013CC0364